Stock screenerAll disclosures → EDGAR →
PDSB
Conviction 24HealthcareScan · Tue, Sep 8, 2026PDSB$0.3059+39.05%
ResistanceSupportVol 14Vol MA14 104.83M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price0.3059
Change+39.05%
Gap+121.77%
Rel volume459.46×
Avg volume75.6M
Avg $ vol22.91M
SMA 200.2243
SMA 500.5435
SMA 2000.8095
Price vs 50-43.72%
Price vs 200-62.21%
MA stackbearish
50/200 cross—
Supertrenddown · 0.3131
RSI (14)43
MACD hist0.03
MACD crossbull · 6d
Stoch %K / %D24 / 45
ADX (14)44
+DI / −DI53 / 19
RSI divergence—
MACD divergence—
ATR %+21.80%
ADR %24.14%
52w high1.43
52w low0.2007
From 52w high-78.61%
Above 52w low+52.42%
New 52w highNo
SqueezeOff
Bollinger width40.37%
%B1.40
Donchian pos22.93%
Donchian high0.6780
Donchian low0.1952
AVWAP (52w high)0.4162
vs AVWAP high-26.50%
AVWAP (52w low)0.4028
vs AVWAP low-24.05%
OBV trendUp
Chaikin MF (20)-0.75
Today vs 20d459.46×
Avg vol (14d)104.83M
Avg vol (20d)75.6M
Avg $ vol (20d)22.91M
Market cap17.12M
RS 3m (vs SPY)-82.86%
RS 6m (vs SPY)-81.85%
RS line new highNo
Trend template1/8
Technical rank8.5
1 week+42.94%
1 month-60.54%
3 months-69.41%
6 months-55.35%
1 year-74.51%
YTD-63.29%
P/E-0.50
P/B-4.78
P/S—
P/FCF-0.62
EPS-0.7400
Div yield—
ROE963.63%
ROA-391.67%
Debt/Eq-4.19
Current0.57
EV/EBITDA-0.84
Gross margin—
Net margin—
Rev growth—
EPS growth8.28%
Price target5.00
Target upside1534.52%
Analyst ratingBuy
Institutional17.34%
Ent. value26.53M
Revenue—
Net income-9.75M
Gross profit—
Free cash flow-27.75M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out55.82M
Employees21
ListedThu, Oct 1, 2015
Free float47.56M
Float %90.8%
Short interest1.89M
Days to cover0.4d
Short volume56.3%
Squeeze score36 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.18 vs −$0.13
Last surprise-38.5% miss
Setup gradeD
Conviction24 / 100
Pattern quality—
Tech rank8.5 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.7885
Support0.1962
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- PDS Biotechnology Corp: Material agreementSEC EDGAR · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in PDSB
No recent disclosed trades by Congress in PDSB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PDSB
No recent insider (Form 4) filings in PDSB. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in PDSB · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.